by Eric Christianson | Dec 11, 2024 | Renal, Urology, and Electrolytes Case Studies
I get a little nervous when I see high-dose potassium. Here’s a case scenario where a patient is on a higher dose. WL is a 77 year old male in an assisted living facility. He has a history of CHF, anxiety, pain, GERD, BPH, and constipation. His current...
by Eric Christianson | Sep 11, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Opvee (nalmefene), is an intranasal opioid antagonist used for opioid overdose and was approved by the FDA in 2023. This approval provided another tool to aid in combating the opioid crisis. There are currently two medications, Opvee and Narcan (naloxone), that can...
by Eric Christianson | Jun 26, 2024 | Clinical Pharmacy News and New Drug Updates, Psychiatry and Addiction Medication and Disease State Clinical Pearls
I’ve encountered a significant proportion of patients who are on chronic benzodiazepines. Drug interactions, adverse effects, and other risks to my geriatric patient population are significant when using this class of medication. Benzodiazepine withdrawal is...
by Eric Christianson | Mar 27, 2024 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
For cancer patients, bone pain can be one of the most distressing symptoms to manage. Whether it’s due to metastasis, chemotherapy-induced effects, or other factors, finding effective pain relief is crucial for improving quality of life. In the realm of pain...
by Eric Christianson | Aug 23, 2023 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Gabapentin is a frequently used medication for neuropathy, RLS, and various other pain syndromes. In this article, I discuss my top 5 reasons to avoid gabapentin use and pick an alternative. Sedation While the sedative nature of gabapentin can be beneficial when...
